Revvity Inc (RVTY)

Sep 15, 2026, 9:05 AM EDT - 4 days ago

Revvity Transcript: 2026 Global Healthcare Conference

Sep 14, 2026, 8:30 AM EDT - 5 days ago

Revvity Transcript: Morgan Stanley 24th Annual Global Healthcare Conference

Sep 9, 2026, 8:45 AM EDT - 10 days ago

Revvity Transcript: Wells Fargo 21st Annual Healthcare Conference

2026-09-09T11:36:45.000Z - 10 days ago

Revvity assumed with a Neutral at UBS

RVTY

2026-09-09T10:05:28.000Z - 10 days ago

Revvity to acquire Human Cell Design

RVTY

Sep 9, 2026, 6:00 AM EDT - 10 days ago

Revvity to Acquire Human Cell Design to Advance Human-Relevant Cell Models for Metabolic Disease Drug Discovery

RVTY

2026-09-04T11:00:21.000Z - 15 days ago

Revvity price target raised to $165 from $125 at KeyBanc

RVTY

2026-09-01T09:15:16.000Z - 19 days ago

Revvity initiated with a Sector Perform at RBC Capital

RVTY

2026-08-25T20:05:19.000Z - 25 days ago

Revvity management to meet with KeyBanc

RVTY

Aug 11, 2026, 8:00 AM EDT - 5 weeks ago

Revvity to Present at Upcoming Investor Conferences

RVTY

Aug 10, 2026, 8:00 AM EDT - 5 weeks ago

Revvity Launches SuperFlex Prenatal Screening System, Expanding Access to Preeclampsia Testing

RVTY

2026-08-05T14:21:00.000Z - 6 weeks ago

Revvity price target raised to $126 from $125 at Evercore ISI

RVTY

2026-08-05T11:10:43.000Z - 6 weeks ago

Revvity price target raised to $110 from $100 at Stifel

RVTY

Aug 4, 2026, 9:52 AM EDT - 6 weeks ago

Revvity raises annual profit, revenue forecasts on strong diagnostics demand

RVTY

Aug 4, 2026, 7:30 AM EDT - 6 weeks ago

Revvity Earnings Call Transcript: Q2 2026

Aug 4, 2026, 7:30 AM EDT - 6 weeks ago

Revvity Slides: Q2 2026

Aug 4, 2026, 7:30 AM EDT - 6 weeks ago

Revvity Earnings release: Q2 2026

Aug 4, 2026, 7:30 AM EDT - 6 weeks ago

Revvity Quarterly report: Q2 2026

2026-08-04T10:16:11.000Z - 6 weeks ago

Revvity reports Q2 adjusted EPS $1.41, consensus $1.22

RVTY

2026-08-04T10:15:58.000Z - 6 weeks ago

Revvity enters definitive agreement to divest China Immunodiagnostics business

RVTY

2026-08-04T10:15:27.000Z - 6 weeks ago

Revvity raises FY26 adjusted EPS view to $5.30-$5.40 from $5.20-$5.30

RVTY

Aug 4, 2026, 6:00 AM EDT - 6 weeks ago

Revvity Announces Financial Results for the Second Quarter of 2026

RVTY

Jul 31, 2026, 4:05 PM EDT - 7 weeks ago

Revvity Board Declares Quarterly Dividend

RVTY

Jul 23, 2026, 8:00 AM EDT - 1 month ago

Revvity Announces Development of High-Throughput T-SPOT.TB Automated Platform for Clinical Labs

RVTY

Jul 20, 2026, 8:00 AM EDT - 2 months ago

Revvity Launches “Signals for Startups” to Help Emerging Biotechs Build Scalable Digital Foundations from Day One

RVTY

Jul 20, 2026, 8:00 AM EDT - 2 months ago

Revvity Releases 2026 Impact Report Advancing Transparency with Initial Scope 3 Emissions Disclosure

RVTY

2026-07-15T12:45:43.000Z - 2 months ago

Revvity price target raised to $130 from $120 at TD Cowen

RVTY

Jul 8, 2026, 8:00 AM EDT - 2 months ago

Revvity to Hold Earnings Call on Tuesday, August 4, 2026

RVTY

2026-07-06T12:50:57.000Z - 2 months ago

Revvity price target raised to $125 from $110 at Evercore ISI

RVTY

2026-07-01T12:16:45.000Z - 2 months ago

Revvity Signals Software business joined Anthropic’s directory

RVTY

Jul 1, 2026, 8:00 AM EDT - 2 months ago

Revvity Expands Signals AI Ecosystem Through Anthropic Claude Integration

RVTY

2026-06-26T10:30:39.000Z - 2 months ago

Revvity resumed with a Market Perform at Bernstein

RVTY

2026-06-22T12:09:26.000Z - 2 months ago

Revvity launches Signals AI framework

RVTY

Jun 22, 2026, 8:00 AM EDT - 2 months ago

Revvity Launches Signals AI, a Native Agentic Framework for Accelerating Scientific R&D

RVTY

Jun 9, 2026, 8:40 AM EDT - 3 months ago

Revvity Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

2026-06-01T20:38:53.000Z - 3 months ago

Revvity assumed with a Peer Perform at Wolfe Research

RVTY

May 13, 2026, 12:20 PM EDT - 4 months ago

Revvity Transcript: Bank of America Global Healthcare Conference 2026

May 13, 2026, 8:00 AM EDT - 4 months ago

Revvity Receives FDA Clearance for Total Testosterone Assay Enabling Comprehensive Automated Testosterone Testing Solution

RVTY

2026-05-07T11:48:56.000Z - 4 months ago

Revvity price target raised to $105 from $95 at Barclays

RVTY

2026-05-07T09:10:40.000Z - 4 months ago

Revvity price target lowered to $117 from $125 at Baird

RVTY

May 5, 2026, 7:30 AM EDT - 4 months ago

Revvity Earnings Call Transcript: Q1 2026

May 5, 2026, 7:30 AM EDT - 4 months ago

Revvity Earnings release: Q1 2026

May 5, 2026, 7:30 AM EDT - 4 months ago

Revvity Slides: Q1 2026

May 5, 2026, 7:30 AM EDT - 4 months ago

Revvity Quarterly report: Q1 2026

May 5, 2026, 6:00 AM EDT - 4 months ago

Revvity Announces Financial Results for the First Quarter of 2026

RVTY

Apr 28, 2026, 8:00 AM EDT - 4 months ago

Revvity Transcript: AGM 2026

Apr 10, 2026, 8:00 AM EDT - 5 months ago

Revvity to Hold Earnings Call on Tuesday, May 5, 2026

RVTY

Apr 9, 2026, 8:00 AM EDT - 5 months ago

Revvity Unveils its Signals BioDesign Offering to Advance Biologic Research Workflows

RVTY

Mar 16, 2026, 8:00 AM EDT - 6 months ago

Revvity Proxy statement: Proxy Filing

Mar 16, 2026, 8:00 AM EDT - 6 months ago

Revvity Proxy statement: Proxy Filing

Mar 10, 2026, 11:30 AM EDT - 6 months ago

Revvity Transcript: Barclays 28th Annual Global Healthcare Conference

Mar 6, 2026, 7:00 AM EST - 6 months ago

Revvity Proxy statement: Proxy Filing

Mar 3, 2026, 2:30 PM EST - 6 months ago

Revvity Transcript: TD Cowen 46th Annual Health Care Conference

Mar 2, 2026, 7:30 AM EST - 6 months ago

Revvity Transcript: 47th Annual Raymond James Institutional Investor Conference

Feb 5, 2026, 8:00 AM EST - 7 months ago

Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026

RVTY

Feb 2, 2026, 8:00 AM EST - 7 months ago

Revvity Earnings Call Transcript: Q4 2025

Feb 2, 2026, 8:00 AM EST - 7 months ago

Revvity Annual report: Q4 2025

Feb 2, 2026, 8:00 AM EST - 7 months ago

Revvity Earnings release: Q4 2025

Feb 2, 2026, 8:00 AM EST - 7 months ago

Revvity Slides: Q4 2025

Feb 2, 2026, 7:13 AM EST - 7 months ago

Revvity forecasts 2026 profit, revenue above estimates after blowout fourth quarter

RVTY

Feb 2, 2026, 6:00 AM EST - 7 months ago

Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2025

RVTY

Jan 13, 2026, 12:45 PM EST - 8 months ago

Revvity Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 12:45 PM EST - 8 months ago

Revvity Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 5:51 AM EST - 8 months ago

Revvity Stock Jumps on Profit Outlook Hike. Why the Shares Are at a Crossroads.

RVTY

Jan 12, 2026, 5:10 PM EST - 8 months ago

Revvity says it will exceed 2025 profit forecast range

RVTY

Jan 12, 2026, 4:15 PM EST - 8 months ago

Revvity to Hold Earnings Call on Monday, February 2, 2026; Provides Update on Financial Performance

RVTY

Jan 9, 2026, 8:00 AM EST - 8 months ago

Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models

RVTY

Dec 18, 2025, 8:00 AM EST - 9 months ago

Revvity to Present at J.P. Morgan Healthcare Conference

RVTY

Dec 16, 2025, 8:00 AM EST - 9 months ago

Revvity Introduces Signals Xynthetica, an AI-Augmented Design Platform for Molecular and Materials Discovery

RVTY

Dec 2, 2025, 9:00 AM EST - 9 months ago

Revvity Transcript: Citi Annual Global Healthcare Conference 2025

Nov 18, 2025, 9:00 AM EST - 10 months ago

Revvity Transcript: Jefferies London Healthcare Conference 2025

Nov 10, 2025, 8:00 AM EST - 10 months ago

Revvity Collaborates with MDIC and NIST to Launch New Somatic Cancer Reference Standards to Monitor Diagnostic Assay Accuracy

RVTY

Nov 10, 2025, 8:00 AM EST - 10 months ago

Revvity Transcript: UBS Global Healthcare Conference 2025

Nov 10, 2025, 7:45 AM EST - 10 months ago

Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities

RVTY

Oct 27, 2025, 8:00 AM EDT - 10 months ago

Revvity Earnings Call Transcript: Q3 2025

Oct 27, 2025, 8:00 AM EDT - 10 months ago

Revvity Quarterly report: Q3 2025

Oct 27, 2025, 8:00 AM EDT - 10 months ago

Revvity Earnings release: Q3 2025

Oct 27, 2025, 8:00 AM EDT - 10 months ago

Revvity Slides: Q3 2025

Oct 27, 2025, 7:06 AM EDT - 10 months ago

Revvity lifts annual profit forecast on renewed demand in diagnostics unit

RVTY

Oct 27, 2025, 6:00 AM EDT - 10 months ago

Revvity Announces Financial Results for the Third Quarter of 2025

RVTY

Oct 14, 2025, 8:00 AM EDT - 11 months ago

Revvity Showcases Progress with Purpose in 2025 Impact Report

RVTY

Oct 6, 2025, 8:00 AM EDT - 11 months ago

Revvity to Hold Earnings Call on Monday, October 27, 2025

RVTY

Oct 2, 2025, 8:00 AM EDT - 11 months ago

Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes

RVTY SNY

Sep 29, 2025, 8:00 AM EDT - 11 months ago

Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis

RVTY

Sep 22, 2025, 8:00 AM EDT - 12 months ago

Revvity and Profluent Collaborate to Launch AI-Enhanced Adenine Deaminase Pin-point Base Editing Systems

RVTY

Sep 9, 2025, 2:35 PM EDT - 1 year ago

Revvity Transcript: Baird Global Healthcare Conference 2025

Sep 3, 2025, 8:00 AM EDT - 1 year ago

Revvity Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Sep 2, 2025, 8:00 AM EDT - 1 year ago

Revvity Establishes In Vivo Imaging Center of Excellence in North Carolina

RVTY

Aug 6, 2025, 8:00 AM EDT - 1 year ago

Revvity Launches Innovative Reagent Technology to Accelerate Development of Next-Generation Targeted Therapeutics

RVTY

Jul 28, 2025, 1:40 PM EDT - 1 year ago

Revvity Stock Sinks on Lowered China Immunodiagnostics Outlook

RVTY

Jul 28, 2025, 12:25 PM EDT - 1 year ago

Top Stock Movers Now: Nike, Cheniere Energy, Revvity, and More

LNG NKE RVTY

Jul 28, 2025, 8:09 AM EDT - 1 year ago

Revvity trims 2025 profit forecast on soft demand for diagnostics in China

RVTY

Jul 28, 2025, 8:00 AM EDT - 1 year ago

Revvity Earnings Call Transcript: Q2 2025

Jul 28, 2025, 8:00 AM EDT - 1 year ago

Revvity Quarterly report: Q2 2025

Jul 28, 2025, 8:00 AM EDT - 1 year ago

Revvity Earnings release: Q2 2025

Jul 28, 2025, 8:00 AM EDT - 1 year ago

Revvity Slides: Q2 2025

Jul 28, 2025, 7:39 AM EDT - 1 year ago

Revvity Stock Tumbles After Earnings. What's Dragging on the Shares.

RVTY

Jul 28, 2025, 6:00 AM EDT - 1 year ago

Revvity Announces Financial Results for the Second Quarter of 2025

RVTY

Jul 7, 2025, 8:00 AM EDT - 1 year ago

Revvity to Hold Earnings Call on Monday, July 28, 2025

RVTY

Jun 10, 2025, 8:00 AM EDT - 1 year ago

Revvity Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

Jun 2, 2025, 8:00 AM EDT - 1 year ago

Revvity Introduces New IVD Reference Standards for Monitoring Oncology Diagnostic Testing Workflows

RVTY

May 19, 2025, 8:00 AM EDT - 1 year ago

Revvity's EUROIMMUN Unveils New Fully Automated Instrument for Specialty Testing

RVTY

May 13, 2025, 12:20 PM EDT - 1 year ago

Revvity Transcript: Bank of America 2025 Healthcare Conference

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Revvity Earnings Call Transcript: Q1 2025

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Revvity Quarterly report: Q1 2025

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Revvity Earnings release: Q1 2025

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Revvity Slides: Q1 2025

Apr 28, 2025, 7:32 AM EDT - 1 year ago

Revvity beats quarterly estimates on steady demand for medical equipment

RVTY

Apr 28, 2025, 6:00 AM EDT - 1 year ago

Revvity Announces Financial Results for the First Quarter of 2025

RVTY

Apr 23, 2025, 8:00 AM EDT - 1 year ago

Watchmaker Genomics and Revvity Team to Automate and Streamline NGS Library Preparation

RVTY

Apr 22, 2025, 8:00 AM EDT - 1 year ago

Revvity Fuels the Future of Cancer Science with New Research Solutions

RSSS RVTY

Apr 3, 2025, 8:00 AM EDT - 1 year ago

Revvity to Hold Earnings Call on Monday, April 28, 2025

RVTY

Apr 2, 2025, 8:00 AM EDT - 1 year ago

Revvity Signals Software Unveils Unified Data Platform to Accelerate Drug Discovery

RVTY